This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Tenofovir alafenamide for prevention of HBV reactivation in HBsAg-negative, anti-HBc-positive patients undergoing rituximab-based chemotherapy: A multicenter randomized controlled trial.
Hepatology communications · 2025
Efficacy of Omalizumab in Indolent Systemic Mastocytosis.
Case reports in hematology · 2019
Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2018
Latest funding
- $199,965
BEFORE (Begin Exploring Fertility Options, Risks and Expectations): a novel Canadian e-health app to facilitate shared decision-making for people at risk of cancer treatment related infertility.
CIHR · 2017 · Co-investigator
- $143,445
Randomized controlled trial of the efficacy of pre-emptive tenofovir to prevent hepatitis B reactivation in patients who are anti-HBc antibody positive receiving curative intent rituximab-based chemotherapy for non-Hodgkin's lympohma
CIHR · 2013 · Principal investigator
- $682,732
A Population-based Study of Cancer Incidence and Mortality in Patients with Solid Organ Transplants
CIHR · 2011 · Co-investigator
5 publications.
Tenofovir alafenamide for prevention of HBV reactivation in HBsAg-negative, anti-HBc-positive patients undergoing rituximab-based chemotherapy: A multicenter randomized controlled trial.
Tabataba Vakili S, Hirode G, Zahoor A, Saunthar A, Feld JB, Hansen BE, Syeda A, Janssen HLA, Kukreti V, Kuruvilla J, Prica A, Cheung M, Buckstein R, Hicks L, Coffin CS, Street LE, Disperati P, Chan KK, Crump M, Feld JJ
Efficacy of Omalizumab in Indolent Systemic Mastocytosis.
Slapnicar C, Trinkaus M, Hicks L, Vadas P
Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation.
Bhella S, Majhail NS, Betcher J, Costa LJ, Daly A, Dandoy CE, DeFilipp Z, Doan V, Gulbis A, Hicks L, Juckett M, Khera N, Krishnan A, Selby G, Shah NN, Stricherz M, Viswabandya A, Bredeson C, Seftel MD
Sarcoidosis-lymphoma syndrome: a diagnostic dilemma.
Oskuei A, Hicks L, Ghaffar H, Hoffstein V
Polyneuropathy: a poetic diagnosis.
Pattani R, Rozenberg D, Mozessohn L, Hicks L
BEFORE (Begin Exploring Fertility Options, Risks and Expectations): a novel Canadian e-health app to facilitate shared decision-making for people at risk of cancer treatment related infertility.
Principal investigators: Baxter, Nancy N
Keywords: Cancer; Decision Support Tools; Fertility Preservation; Health Behaviour Change; Health Services Research; Oncofertility; Qualitative Research; Shared Decision-Making; Treatment-Related Infertility; Young Adult
Randomized controlled trial of the efficacy of pre-emptive tenofovir to prevent hepatitis B reactivation in patients who are anti-HBc antibody positive receiving curative intent rituximab-based chemotherapy for non-Hodgkin's lympohma
Principal investigators: Feld, Jordan J; Chan, Kelvin K; Hicks, Lisa K
Keywords: Chemotherapy; Hepatitis B; Randomized Controlled Trial; Reactivation; Reverse Seroconversion; Rituximab; Tenofovir
A Population-based Study of Cancer Incidence and Mortality in Patients with Solid Organ Transplants
Principal investigators: Baxter, Nancy N
Keywords: Cancer Incidence; Cancer Outcomes; Cancer Treatment; Immunosuppression; Non-Randomized Design; Population-Based Data; Transplantation
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- John Kuruvilla and Lee Mozessohn: 2 shared papers
- Lisa Hicks and John Kuruvilla: 1 shared paper
- Lisa Hicks and Lee Mozessohn: 1 shared paper
- Lisa Hicks and Dmitry Rozenberg: 1 shared paper
- Lisa Hicks and Christopher Bredeson: 1 shared paper
- John Kuruvilla and Dmitry Rozenberg: 1 shared paper
- Lee Mozessohn and Dmitry Rozenberg: 1 shared paper
- Lee Mozessohn and Christopher Bredeson: 1 shared paper
- Department of Medicine
- Medicine/Respirology
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.